Kissei Pharmaceutical Co (TSE:4547) Beneish M-Score: -2.15 (As of Aug. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4547 Kissei Pharmaceutical Co Ltd TSE:4547
79 GF Score
Price 円3,860.00
GF Value 円4,688.48
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Kissei Pharmaceutical Co Beneish M-Score?

Kissei Pharmaceutical Co TSE:4547 +0.13% 79 Beneish M-Score is -2.15 as of Aug. 04, 2026. GuruFocus rates TSE:4547 with a GF Score™ of 79/100 and a GF Value™ of 円4,688.48 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 912 Drug Manufacturers companies, Kissei Pharmaceutical Co ranks worse than 72.92% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.15 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Kissei Pharmaceutical Co's Beneish M-Score or its related term are showing as below:

TSE:4547' s Beneish M-Score Range Over the Past 10 Years
Min: -2.86   Med: -2.31   Max: -1.98
Current: -2.15

During the past 13 years, the highest Beneish M-Score of Kissei Pharmaceutical Co was -1.98. The lowest was -2.86. And the median was -2.31.


Kissei Pharmaceutical Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Kissei Pharmaceutical Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kissei Pharmaceutical Co Beneish M-Score Chart

Kissei Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.39 -2.12 -1.98 -2.38 -2.15

Kissei Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -2.15 0.00

TSE:4547 vs ZTS: Beneish M-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kissei Pharmaceutical Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kissei Pharmaceutical Co Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kissei Pharmaceutical Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Kissei Pharmaceutical Co's Beneish M-Score falls into.


TSE:4547
79GF Score
Kissei Pharmaceutical Co Ltd TSE:4547
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kissei Pharmaceutical Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Kissei Pharmaceutical Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9658+0.528 * 1.0606+0.404 * 1.0647+0.892 * 1.1028+0.115 * 1.0268
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1+4.679 * 0.055488-0.327 * 1.1607
=-2.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was 円31,582 Mil.
Revenue was 円97,406 Mil.
Gross Profit was 円45,818 Mil.
Total Current Assets was 円114,969 Mil.
Total Assets was 円275,086 Mil.
Property, Plant and Equipment(Net PPE) was 円28,093 Mil.
Depreciation, Depletion and Amortization(DDA) was 円4,644 Mil.
Selling, General, & Admin. Expense(SGA) was 円0 Mil.
Total Current Liabilities was 円21,688 Mil.
Long-Term Debt & Capital Lease Obligation was 円0 Mil.
Net Income was 円13,779 Mil.
Gross Profit was 円0 Mil.
Cash Flow from Operations was 円-1,485 Mil.
Total Receivables was 円29,653 Mil.
Revenue was 円88,330 Mil.
Gross Profit was 円44,065 Mil.
Total Current Assets was 円106,980 Mil.
Total Assets was 円244,059 Mil.
Property, Plant and Equipment(Net PPE) was 円27,069 Mil.
Depreciation, Depletion and Amortization(DDA) was 円4,615 Mil.
Selling, General, & Admin. Expense(SGA) was 円0 Mil.
Total Current Liabilities was 円16,578 Mil.
Long-Term Debt & Capital Lease Obligation was 円0 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(31582 / 97406) / (29653 / 88330)
=0.324231 / 0.335707
=0.9658

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(44065 / 88330) / (45818 / 97406)
=0.498868 / 0.470382
=1.0606

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (114969 + 28093) / 275086) / (1 - (106980 + 27069) / 244059)
=0.479937 / 0.450752
=1.0647

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=97406 / 88330
=1.1028

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(4615 / (4615 + 27069)) / (4644 / (4644 + 28093))
=0.145657 / 0.141858
=1.0268

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 97406) / (0 / 88330)
=0 / 0
=1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 21688) / 275086) / ((0 + 16578) / 244059)
=0.078841 / 0.067926
=1.1607

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(13779 - 0 - -1485) / 275086
=0.055488

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Kissei Pharmaceutical Co has a M-score of -2.15 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.15 mean?
Kissei Pharmaceutical Co (TSE:4547) has a Beneish M-Score of -2.15 as of Aug. 04, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Kissei Pharmaceutical Co and its competitors. According to the industry distribution chart, Kissei Pharmaceutical Co ranks #665 out of 912 companies in the Drug Manufacturers industry, placing it in the top 72.9%.
Is Kissei Pharmaceutical Co's Beneish M-Score too high?
Kissei Pharmaceutical Co's current Beneish M-Score is -2.15. Based on the distribution chart, Kissei Pharmaceutical Co ranks #665 out of 912 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Kissei Pharmaceutical Co has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kissei Pharmaceutical Co's Beneish M-Score compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Kissei Pharmaceutical Co ranks #665 out of 912 companies for Beneish M-Score. This places Kissei Pharmaceutical Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Drug Manufacturers company?
A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Kissei Pharmaceutical Co and its competitors. Kissei Pharmaceutical Co's current Beneish M-Score is -2.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kissei Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Kissei Pharmaceutical Co (TSE:4547) is currently considered Modestly Undervalued. The stock's GF Value™ is 円4,688.48, compared to a current price of 円3,860.00 — trading 17.7% below its estimated fair value. The current Beneish M-Score is -2.15. Kissei Pharmaceutical Co's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Kissei Pharmaceutical Co (TSE:4547), the current Beneish M-Score is -2.15 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kissei Pharmaceutical Co (TSE:4547) Overvalued in 2026?

Based on GuruFocus' analysis, Kissei Pharmaceutical Co stock appears to be undervalued. The current stock price of 円3,860.00 is trading 17.7% below its estimated GF Value™ of 円4,688.48. GuruFocus considers Kissei Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for TSE:4547:

  • Beneish M-Score: -2.15
  • GF Value™: 円4,688.48 vs. price of 円3,860.00 (17.7% below fair value)
  • GF Score™: 79/100 with 1 warning sign

No single metric tells the full story. See the TSE:4547 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kissei Pharmaceutical Co Business Description

Address 19-48, Yoshino, Matsumoto City, Nagano, JPN, 399-8710
Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. Pharmaceuticals is the company's reportable segment. The company's operations span across the globe, while the vast majority of revenue is generated in Japan, followed by Europe. Kissei operates a variety of subsidiaries. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
79GF Score

Get the complete analysis for TSE:4547

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,860.00
Price
円4,688.48
GF Value